Erasca, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Erasca, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($124.55M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($161.65M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($125.04M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($242.81M) | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | ($122.76M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($101.66M) | Mar 24, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($140.91M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($179.59M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($141.53M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($247.45M) | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | ($124.88M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($109.25M) | Mar 24, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($95.46M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($109.42M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($101.22M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($103.26M) | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | ($79.60M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($32.69M) | Mar 24, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $128.0K | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $60.0K | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.78M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $14.55M | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | $11.21M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $947.0K | Mar 24, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $396.15M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $502.53M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $395.30M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $514.91M | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | $501.42M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $124.83M | Mar 24, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $70.98M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $79.03M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $78.61M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $103.06M | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | $44.89M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $17.40M | Mar 24, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $325.17M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $423.50M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $316.69M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $411.85M | Mar 20, 2025 |
| FY2023 | Dec 31, 2021 | $456.53M | Mar 27, 2024 |
| FY2022 | Dec 31, 2020 | ($113.98M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2019 | ($13.60M) | Mar 24, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($892.21M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($767.66M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($606.01M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($480.97M) | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | ($238.17M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($115.40M) | Mar 24, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $73.81M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $67.74M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $93.08M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $284.22M | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | $360.49M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $65.38M | Mar 24, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | (1) | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Mar 23, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | (1) | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Mar 23, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 284.16M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 283.22M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 151.09M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | 149.33M | Mar 27, 2024 |
| FY2022 | Dec 31, 2021 | 119.10M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 21.92M | Mar 24, 2022 |